Founder Variants in the Mexican Population: A Systematic Review.

Arch Med Res

Laboratorio de Medicina de Precisión, Instituto Nacional de Cancerología, Mexico City, Mexico; Genetista, Centro Médico ABC, Mexico City, Mexico. Electronic address:

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Founder variants (FVs) are genetic alterations inherited from a common ancestor that are frequently observed in genetically homogeneous populations. FVs significantly influence the prevalence of genetic disorders in specific populations; however, these variants have never been comprehensively described for the Mexican population.

Aim: This systematic review aimed to summarize and describe FVs of Mexican origin and their association with specific health conditions.

Methods: Studies were retrieved from the LILACS, COCHRANE, Scopus, and PubMed databases using a pre-specified search string. Information on genes, variants, and haplotypes that met the inclusion criteria was extracted from the articles. Based on the evidence provided, variants originating in the Mexican population were stratified according to whether they had strong or weak evidence for classification as FVs.

Results: A total of 32 studies were selected, describing 19 genes and 21 FVs. These include variants associated with a variety of diseases, such as Stargardt disease, breast and ovarian cancer, Fanconi anemia, congenital muscular dystrophy, and familial hypercholesterolemia. Haplotype analysis revealed that some variants, although frequent in the Mexican population, appear to be of European origin, as their haplotypes match those found in European populations and may represent variants introduced into Mexican territory following the Spanish conquest in the early 16th century.

Conclusion: These results provide a comprehensive view of the FVs present in the Mexican population, increasing our understanding of the genetic architecture in this region. In addition, they provide a broad context to elucidate potential associations between FVs and clinical, historical, and cultural findings.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arcmed.2025.103209DOI Listing

Publication Analysis

Top Keywords

mexican population
16
founder variants
8
systematic review
8
fvs mexican
8
mexican
7
variants
7
fvs
6
variants mexican
4
population
4
population systematic
4

Similar Publications

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which dysregulated interferon regulatory factor 5 (IRF5) may amplify pro-inflammatory pathways; prior genetic studies of IRF5 single-nucleotide variants (SNVs) in RA are inconsistent across populations and have not included mestizo Mexicans or evaluated rs59110799 in RA. We aimed to test whether four IRF5 SNVs (rs2004640G/T, rs2070197T/C, rs10954213G/A, rs59110799G/T) confer susceptibility to RA in women from Central Mexico. In a case-control study of 239 women with RA and 231 female controls (all self-identified Mexican-Mestizos, ≥3 generations), genotyping was performed by real-time PCR with TaqMan® probes; 80% of samples were duplicated (100% concordance) and control genotypes conformed to Hardy-Weinberg equilibrium.

View Article and Find Full Text PDF

Background: Hispanics/Latinos are a heterogenous population with no validated atherosclerotic cardiovascular disease (ASCVD) risk estimation tool. We examined performance of the pooled cohort equation (PCE) across Hispanic/Latino background groups and quantiles of African, Amerindian, and European genetic ancestry.

Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) was used to evaluate the performance of the non-Hispanic Black (NHB) and non-Hispanic White (NHW) PCE defined by predicted to observed (P/O) ratios of 10-year ASCVD events.

View Article and Find Full Text PDF

Background: The 2025-30 US Dietary Guidelines Advisory Committee has recommended moving pulses to the Protein Foods Group and listing them ahead of meat, poultry, and eggs. The recommended amounts went up from 1.5 to 2.

View Article and Find Full Text PDF

Elevated Hypertension Risk among Mexican Patients with Hemophilia.

Curr Hypertens Rev

September 2025

Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Introduction: Epidemiological evidence suggests that people with hemophilia (PWH) have a higher prevalence of comorbidities compared to the general population. However, the incidence and risk of comorbidities, particularly hypertension, among Mexican PWH remain underexplored.

Methods: We conducted a retrospective cross-sectional study on adult PWH at a major hemophilia treatment center in Mexico.

View Article and Find Full Text PDF